Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 13:30:326.
eCollection 2016.

Cost effectiveness of type 2 diabetes screening: A systematic review

Behzad Najafi  1 , Farshad Farzadfar  2 , Hossein Ghaderi  3 , Mohammad Hadian  4
Affiliations

Cost effectiveness of type 2 diabetes screening: A systematic review

Behzad Najafi et al. Med J Islam Repub Iran. .

Abstract

Background: Although studies reported diabetes mellitus screening cost effective, the mass screening for type2 diabetes remains controversial. In this study we reviewed the recently evidence about the cost effectiveness of mass screening systematically.

Methods: We reviewed the MEDLINE, Scopus, Web of Science (WOS), and Cochrane library databases by MeSH terms to identify relevant studies from 2000 to 2013. We had 4 inclusion and 6 exclusion criteria and used the Drummond's checklist for appraising the quality of studies.

Results: The initial search yielded 358 potentially related studies from selected databases. 6 studies met our inclusion and exclusion criteria and included in final review. 3 and 2 of them were conducted in Europe and America and only one of them in Asia. Quality-adjusted life year (QALY) was the main outcome to appraise the effectiveness in the studies. Incremental cost effectiveness ratio (ICER) was computed in range from $516.33 to $126,238 per QALY in the studies.

Conclusion: A review of previous diabetes screening cost effectiveness analysis showed that the studies varied in some aspects but reached similar conclusions. They concluded that the screening may be cost effective, however further studies is required to support the diabetes mass screening.

Keywords: Cost effectiveness; Diabetes; Economic evaluation; Screening.

PubMed Disclaimer

References

    1. Durand CP. A systematic review and meta-analysis of diabetes disease management programs [MSc Thesis] [Internet]. ProQuest; 2008. Available from: Texas Medical Center Dissertations (via ProQuest). /http://digitalcommons.library.tmc.edu/dissertations/AAI1454501.
    1. Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010Diabetes Res. Clin Pract Elsevier. 2010;87(1):15–19. - PubMed
    1. Kiadaliri A, Najafi B. Obesity in type 2 diabetes mellitus: a review of health economics’ evidences. Int J Heal Insur Equity. 2013;1(1):2–13.
    1. Lawrence J, Robinson A. Screening for diabetes in general practice. Prev Cardiol. 2003;6(2):78–84. - PubMed
    1. Kahn R, Alperin P, Eddy D, Borch-Johnsen K, Buse J, Feigelman J, et al. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. Lancet. 2010/04/02 ed. 2010;375(9723):1365–74. - PubMed

LinkOut - more resources